These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29580115)

  • 21. Platelet function testing: dead or alive.
    Helten C; Naguib D; Dannenberg L; Pöhl M; Ayhan A; Hohlfeld T; Levkau B; Kelm M; Zeus T; Polzin A
    J Thromb Haemost; 2018 May; 16(5):984-986. PubMed ID: 29512292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is platelet inhibition correlated with time from last intake on P2Y12 blockers after an acute coronary syndrome? A pilot study.
    Deharo P; Quilici J; Bonnet G; Grosdidier C; Morange P; Alessi MC; Bonnet JL; Cuisset T
    Platelets; 2016 Dec; 27(8):791-795. PubMed ID: 27275528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
    Gremmel T; Koppensteiner R; Panzer S
    PLoS One; 2015; 10(6):e0129666. PubMed ID: 26058047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia.
    Clavijo LC; Al-Asady N; Dhillon A; Matthews RV; Caro J; Tun H; Rowe V; Shavelle DM
    Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):516-520. PubMed ID: 29221961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
    Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry.
    von Beckerath N; Sibbing D; Jawansky S; Braun S; Morath T; Vogt W; Schömig A; Kastrati A
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):46-52. PubMed ID: 19823079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y
    Brambilla M; Becchetti A; Rovati GE; Cosentino N; Conti M; Canzano P; Giesen PLA; Loffreda A; Bonomi A; Cattaneo M; De Candia E; Podda GM; Trabattoni D; Werba PJ; Campodonico J; Pinna C; Marenzi G; Tremoli E; Camera M
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2042-2057. PubMed ID: 37589138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention.
    Gaglia MA; Torguson R; Pakala R; Xue Z; Sardi G; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    J Interv Cardiol; 2011 Dec; 24(6):529-34. PubMed ID: 21919956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention.
    Jang J; Lim J; Chang K; Kim Y; Kim M; Park HI; Kim J; Shin S
    J Clin Lab Anal; 2012 Jul; 26(4):262-6. PubMed ID: 22811359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay.
    Abtan J; Silvain J; Kerneis M; O'Connor SA; Barthélémy O; Vignalou JB; Beygui F; Brugier D; Collet JP; Montalescot G
    Thromb Haemost; 2013 Nov; 110(5):1055-64. PubMed ID: 23925438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in response to clopidogrel therapy in patients after percutaneous coronary interventions as assessed by different platelet function tests.
    Golański J; Syska K; Chiżynski K; Kassasir H; Watała C; Sakowicz A; Kuliczkowski W
    Pol Arch Med Wewn; 2016 Aug; 126(9):653-661. PubMed ID: 27534914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
    Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G
    Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition.
    Koessler J; Kobsar AL; Rajkovic MS; Schafer A; Flierl U; Pfoertsch S; Bauersachs J; Steigerwald U; Rechner AR; Walter U
    Platelets; 2011; 22(1):20-7. PubMed ID: 20873965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.
    Siller-Matula JM; Christ G; Lang IM; Delle-Karth G; Huber K; Jilma B
    J Thromb Haemost; 2010 Feb; 8(2):351-9. PubMed ID: 19943879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in high on-treatment platelet reactivity between intra-coronary and peripheral blood after dual anti-platelet agents in patients with coronary artery disease.
    Hu YF; Lu TM; Wu CH; Lin YJ; Chang SL; Lo LW; Tuan TC; Chao TF; Chung FP; Liao JN; Tzeng CH; Chen SA; Tsao HM
    Thromb Haemost; 2013 Jul; 110(1):124-30. PubMed ID: 23677387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y
    Rollini F; Franchi F; Singh K; Cho JR; Bhatti M; DeGroat C; Hu J; Aggarwal N; Alobaidi Z; Thano E; Ferrante E; Zenni M; Bass TA; Angiolillo DJ
    Thromb Haemost; 2016 Nov; 116(6):1060-1069. PubMed ID: 27488362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events.
    Freynhofer MK; Brozovic I; Bruno V; Farhan S; Vogel B; Jakl G; Willheim M; Hübl W; Wojta J; Huber K
    Thromb Haemost; 2011 Aug; 106(2):230-9. PubMed ID: 21614416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.